ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $42,172,000 | 23.15% |
| Octagon Capital Advisors LP | 2,668,316 | $69,803,000 | 12.05% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,754,000 | 8.25% |
| Finepoint Capital LP | 646,586 | $16,915,000 | 5.56% |
| PFM Health Sciences, LP | 3,383,233 | $88,505,000 | 3.20% |
| BVF INC/IL | 2,717,020 | $71,077,000 | 2.94% |
| Boxer Capital, LLC | 1,432,200 | $37,466,000 | 2.11% |
| DAFNA Capital Management LLC | 178,717 | $4,675,000 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 227,032 | $5,939,000 | 1.17% |
| HighVista Strategies LLC | 71,650 | $1,874,000 | 1.07% |